Series A · AI & Machine Learning · Hamburg, Germany · Founded 2018 · 40–50 employees
Mindpeak develops AI-powered software for automated pathological image analysis to assist cancer experts in providing reliable and reproducible diagnoses. Their solutions help pathologists by automating tedious tasks like tumor cell quantification and biomarker analysis, freeing specialists to focus on complex cases. The company has achieved significant clinical validation with their AI algorithms being among the first deployed for routine clinical diagnostics in both the US and EU, with over 20,000 patients already diagnosed using their technology. They recently raised $15.3 million in Series A funding led by ZEISS Ventures and have partnerships with renowned institutions including Charité Berlin and leading pathology labs.